Mannkind (MNKD) Interest & Investment Income (2010 - 2026)
Mannkind (MNKD) reported Interest & Investment Income of $1.4 million for Q1 2026, down 26.94% year-over-year from $2.0 million in Q1 2025, and down 12.71% quarter-over-quarter from $1.6 million in Q4 2025.
Mannkind (MNKD) Interest & Investment Income (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Interest & Investment Income data on file, last reported at $1.4 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $1.4 million, down 26.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.5 million (down 32.42% YoY), and the FY2025 annual result was $8.1 million, down 36.16% from the prior year.
- Interest & Investment Income slipped to $1.4 million in Q1 2026 per MNKD's latest filing, from $1.6 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $3.4 million in Q1 2024 and troughed at $377000.0 in Q1 2022.
- A 5-year average of $1.8 million and a median of $1.6 million in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income jumped 12466.67% in 2022, then plunged 43.04% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $957000.0 in 2022, then jumped by 80.25% to $1.7 million in 2023, then surged by 63.77% to $2.8 million in 2024, then slumped by 42.05% to $1.6 million in 2025, then fell by 12.71% to $1.4 million in 2026.
- Business Quant data shows MNKD's Interest & Investment Income at $1.4 million in Q1 2026, $1.6 million in Q4 2025, and $2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Mannkind | 1.13 Bn | 995.19 Mn | 82.66 Mn | 1.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 2.63 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 1.96 Mn |
| Dec 31, 2024 | 2.83 Mn |
| Sep 30, 2024 | 3.18 Mn |
| Jun 30, 2024 | 3.18 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 957,000.00 |
| Sep 30, 2022 | 663,000.00 |
| Jun 30, 2022 | 516,000.00 |
| Mar 31, 2022 | 377,000.00 |
| Dec 31, 2021 | 48,000.00 |
| Sep 30, 2021 | 36,000.00 |
| Jun 30, 2021 | 25,000.00 |